In the meantime, however, he has sought to limit the staff to the three lowest-cost knee implants.

NEWYORKER: Big Med

Dr. JOSHUA OFMAN (Vice President, Amgen): The FDA label acknowledges that a certain risks cannot be excluded, but they have clearly stated that the lowest dose should be use to avoid transfusion with an upper safety limit of 12, leaving some discretion for physicians to make those determinations based on their individual patient needs.

NPR: Doctors in Medicare Fight Over Right to Prescribe